Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Return on Equity (2021 - 2025)

Verrica Pharmaceuticals has reported Return on Equity over the past 5 years, most recently at 4.93% for Q4 2025.

  • Quarterly results put Return on Equity at 4.93% for Q4 2025, down 830.0% from a year ago — trailing twelve months through Dec 2025 was 4.93% (down 830.0% YoY), and the annual figure for FY2025 was 2.55%, up 1237.0%.
  • Return on Equity for Q4 2025 was 4.93% at Verrica Pharmaceuticals, down from 1.4% in the prior quarter.
  • Over the last five years, Return on Equity for VRCA hit a ceiling of 14.74% in Q2 2024 and a floor of 7.59% in Q1 2024.
  • Median Return on Equity over the past 5 years was 0.54% (2022), compared with a mean of 0.47%.
  • Biggest five-year swings in Return on Equity: soared 1510bps in 2024 and later plummeted -1214bps in 2025.
  • Verrica Pharmaceuticals' Return on Equity stood at 0.96% in 2021, then surged by 43bps to 0.54% in 2022, then plummeted by -297bps to 2.16% in 2023, then soared by 256bps to 3.37% in 2024, then tumbled by -247bps to 4.93% in 2025.
  • The last three reported values for Return on Equity were 4.93% (Q4 2025), 1.4% (Q3 2025), and 2.6% (Q2 2025) per Business Quant data.